SCHEMBL688551

SCHEMBL688551

CSCc1ccc(C(F)(F)F)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 3/20 0.50
▸ TRPV4 Q9HBA0 1/20 0.47
▸ TKT P29401 1/20 0.41
▸ KDM1A O60341 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ CYP3A4 P08684 1/20 0.36
▸ CYP3A5 P20815 1/20 0.36
▸ PPARD Q03181 1/20 0.36
▸ KCNQ3 O43525 1/20 0.35
▸ KCNQ2 O43526 1/20 0.35
▸ KCNQ4 P56696 1/20 0.35
▸ KCNQ5 Q9NR82 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ GRIN1 Q05586 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PIK3CB P42338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12464342 0.87 DAO (0.40) DAOTRPV4TKTKDM1AMAOA
SCHEMBL1958711 0.87 DAO (0.40) DAOTRPV4TKTKDM1AMAOA
SCHEMBL12463911 0.86 DAO (0.39) DAOTRPV4TKTKDM1AMAOA
SCHEMBL1819962 0.82 DAO (0.47) DAOTRPV4TKTKDM1AMAOA
SCHEMBL13356156 0.81 DAO (0.50) DAOTRPV4TKTKDM1AMAOA
SCHEMBL1146015 0.81 DAO (0.50) DAOTRPV4TKTKDM1AMAOA
SCHEMBL91511 0.79 TRPV4 (0.52) DAOTRPV4TKTKDM1AMAOA
SCHEMBL22788217 0.77 TRPV4 (0.43) DAOTRPV4TKTKDM1AMAOA
SCHEMBL18405131 0.77 DAO (0.44) DAOTRPV4TKTKDM1AMAOA
Bromide SCHEMBL28647835 0.77 TRPV4 (0.50) DAOTRPV4TKTKDM1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787780-B2 Quaternary indazole glucocorticoid receptor antagonists CORCEPT THERAPEUTICS INCORPORATED (US) 2023-10-17 — — US disclosed
US-20230032612-A1 QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS CORCEPT THERAPEUTICS INCORPORATED 2023-02-02 — — US disclosed
WO-2020252229-A2 INHIBITORS OF SARM1 DISARM THERAPEUTICS, INC. (US) 2020-12-17 — — WO disclosed
EP-3120701-B1 STABLE SULFOXIMINE-INSECTICIDE COMPOSITIONS DOW AGROSCIENCES LLC (US) 2019-08-28 — — EP disclosed
EP-2338882-B1 2-((6-(Haloalkyl substituted))pyridin-3-yl)-tetrahydro-1H-1(lamba)4-thien-1-ylidenecyanamide derivatives and related compounds as pesticides and insecticides DOW AGROSCIENCES LLC (US) 2017-06-07 — — EP disclosed
EP-3120701-A1 STABLE SULFOXIMINE-INSECTICIDE COMPOSITIONS Dow AgroSciences LLC (US) 2017-01-25 — — EP disclosed
EP-2369935-B1 STABLE INSECTICIDE COMPOSITIONS AND METHODS FOR PRODUCING SAME DOW AGROSCIENCES LLC (US) 2016-07-27 — — EP disclosed
EP-2369921-B1 STABLE SULFOXIMINE-INSECTICIDE COMPOSITIONS DOW AGROSCIENCES LLC (US) 2016-07-27 — — EP disclosed
CN-103641826-B Sterilant and uses thereof DOW AGROSCIENCES LLC (US) 2016-04-20 — — CN disclosed
CN-103694235-B Sterilant and uses thereof DOW AGROSCIENCES LLC (US) 2016-04-20 — — CN disclosed
WO-2007149134-A1 A METHOD TO CONTROL INSECTS RESISTANT TO COMMON INSECTICIDES DOW AGROSCIENCES LLC (US) 2007-12-27 — — WO disclosed
US-20070203191-A1 Insecticidal N-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines CORTEVA AGRISCIENCE LLC 2007-08-30 — — US disclosed
US-20070203191-A1 Insecticidal N-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines CORTEVA AGRISCIENCE LLC 2007-08-30 — — US disclosed
WO-2007095229-A2 INSECTICIDAL N-SUBSTITUTED (6-HALOALKYLPYRIDIN-3-YL)ALKYL SULFOXIMINES DOW AGROSCIENCES LLC (US) 2007-08-23 — — WO disclosed
WO-2006083673-A2 PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF C-JUN N-TERMINAL KINASES ABBOTT LABORATORIES (US) 2006-08-10 — — WO disclosed
US-20060173050-A1 Inhibitors of c-Jun N-terminal kinases ABBVIE INC. 2006-08-03 — — US disclosed
US-20050171132-A1 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists XIN ZHILI (US) 2005-08-04 — — US disclosed
US-20050171131-A1 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists KOSOGOF CHRISTI (US) 2005-08-04 — — US disclosed
WO-2005030734-A1 DIAMINOPYRIMIDINE DERIVATIVES AS SELECTIVE GROWTH HORMONE SECRECTGOGUE RECEPTOR (GHS-R) ANTAGONISTS ABBOTT LABORATORIES (US) 2005-04-07 — — WO disclosed
US-20050070712-A1 Pyrimidine derivatives as ghrelin receptor modulators ABBOTT LABORATORIES 2005-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787780-B2 Quaternary indazole glucocorticoid receptor antagonists NR3C1, NR3C2, MC2R DAO 4612/4885TRPV4 3058/4885TKT 4388/4885
US-20230032612-A1 QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS NR3C1, NR3C2, MC2R DAO 4612/4885TRPV4 3058/4885TKT 4388/4885
US-20060173050-A1 Inhibitors of c-Jun N-terminal kinases MAPKAPK3, MAP3K3, MAPK3 DAO 2793/4885TRPV4 4516/4885TKT 754/4885
US-20050171131-A1 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists GHSR, GIPR, GPR119 DAO 260/4885TRPV4 3734/4885TKT 2774/4885
US-20050171132-A1 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists GHSR, GIPR, GPR119 DAO 305/4885TRPV4 3721/4885TKT 2510/4885
US-20070203191-A1 Insecticidal N-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines NPEPPS, PRDX6, HDHD5 DAO 124/4885TRPV4 1575/4885TKT 3272/4885
US-20050070712-A1 Pyrimidine derivatives as ghrelin receptor modulators GPR119, GIPR, GCGR DAO 466/4885TRPV4 2088/4885TKT 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback